Leading brokers name 3 ASX shares to buy today

With so many shares to choose from on the ASX, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares that leading brokers have named as buys this week are listed below. Here’s why they are bullish on them:

Accent Group Ltd (ASX: AX1)

According to a note out of Morgans, its analysts have retained their add rating and $2.30 price target on this footwear retailer’s shares. Although Accent’s half year results were short of expectations, the broker remains positive. Particularly given that comparable sales will get less demanding as the half goes on. Morgans expects this to lead to positive like for like sales for the second half. The Accent share price is trading at $1.96 today.

Pro Medicus Limited (ASX: PME)

A note out of Macquarie reveals that its analysts have retained their outperform rating and $120.00 price target on this health imaging technology company’s shares. The broker believes that recent share price weakness has created a buying opportunity for investors. Especially now they are trading on multiples that are largely in line with five-year averages. The Pro Medicus share price is fetching $98.39 on Monday.

Xero Ltd (ASX: XRO)

Analysts at Goldman Sachs have reiterated their buy rating and $141.00 price target on this cloud accounting platform provider’s shares. The broker is feeling positive on Xero’s outlook ahead of its investor day event this week. It highlights that it is forecasting revenue to grow to NZ$3 billion by FY 2028. This represents a 16% CAGR (14% subs growth and +2% ARPU). The Xero share price is trading at $122.72 this afternoon.

The post Leading brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Buying Xero shares? Here’s what to expect from this week’s update
• I’d buy these great ASX growth shares in March
• 5 things to watch on the ASX 200 on Monday
• Here’s how the ASX 200 market sectors stacked up this week
• Here are the top 10 ASX 200 shares today

Motley Fool contributor James Mickleboro has positions in Xero. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Macquarie Group, Pro Medicus, and Xero. The Motley Fool Australia has positions in and has recommended Macquarie Group and Xero. The Motley Fool Australia has recommended Accent Group and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/8uiEIJ2